Search - tctmd.com

Displaying 661 - 680 of 704

Sort: Relevancy | Date

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: Emerging Opportunities for Future TAVR Development: Stroke, Paravalvular Leaks, and Beyond

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Is There a Higher Risk of Stroke With the Radial Approach? Reasons and Results

Presenter: Martial Hamon

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Acute Success Rates, Complication, and Long-term Stroke Risks After AF Ablation: A Critical Appraisal of a Mixed Literature

Presenter: Shephal Doshi

October 23, 2012

News Conference News TCT 2012

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

October 23, 2012

News Conference News TCT 2012

Registries Show Low Complication Rates With New Heart Valves

October 23, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

Presentation TCT 2012

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

Presenter: Josep Rodes-Cabau

October 22, 2012

Presentation TCT 2012

Stroke Risk After TAVR: Results from a Large Meta-analysis

Presenter: Raimund Erbel

October 22, 2012

Presentation TCT 2012

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Presenter: Dirk Sibbing

October 22, 2012

Presentation TCT 2012

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

Presenter: David Thaler

October 22, 2012

Presentation TCT 2012

BUT May Also Increase Stroke

Presenter: Josep Rodes-Cabau

October 22, 2012

Presentation TCT 2012

Bottom Line: What Is the Relative Importance of Stroke Risk After TAVR Compared to Surgery?

Presenter: Samir Kapadia

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Conference News TCT 2012

PCI Associated with Lower Stroke Risk Than CABG

October 22, 2012

Presentation TCT 2012

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

October 22, 2012

Presentation TCT 2012

Selective Basilar Artery Thrombolysis For Posterior Territory Stroke: Acute Stroke Registry From Western India

Presenter: Kamaldeep Chawla, Keyur Buch

January 03, 2012

Advertisement

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

State-of-the-Field Keynote: Emerging Opportunities for Future TAVR Development: Stroke, Paravalvular Leaks, and Beyond

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Is There a Higher Risk of Stroke With the Radial Approach? Reasons and Results

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Acute Success Rates, Complication, and Long-term Stroke Risks After AF Ablation: A Critical Appraisal of a Mixed Literature

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

Registries Show Low Complication Rates With New Heart Valves

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

Stroke Risk After TAVR: Results from a Large Meta-analysis

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

BUT May Also Increase Stroke

Bottom Line: What Is the Relative Importance of Stroke Risk After TAVR Compared to Surgery?

Review of TAVR Use Offers Significant Advances, Positive Outcomes

PCI Associated with Lower Stroke Risk Than CABG

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Selective Basilar Artery Thrombolysis For Posterior Territory Stroke: Acute Stroke Registry From Western India

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content